Condition
Narcolepsy Type 1 (NT 1)
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Recruiting2
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06809803Phase 2RecruitingPrimary
Extended-release Sodium Oxybate in Children
NCT07006233Not ApplicableRecruiting
A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia
NCT04820842Phase 2TerminatedPrimary
A Study of TAK-994 in Adults With Narcolepsy
Showing all 3 trials